CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for advanced Hodgkin's lymphoma
Disease control OngoingThis study tests a new combination of the immunotherapy drug camrelizumab plus chemotherapy (AVD) as a first treatment for people with advanced classical Hodgkin's lymphoma. The goal is to see if this combo can make the cancer disappear completely. About 60 adults aged 18-75 who …
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 11:39 UTC
-
New drug combo shows promise for Tough-to-Treat hodgkin lymphoma
Disease control OngoingThis study tests a combination of two drugs, ibrutinib and nivolumab, in adults with classical Hodgkin lymphoma that returned or didn't respond to prior treatment. The goal is to see if the combination can shrink or eliminate cancer. About 18 participants will receive both drugs,…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:35 UTC